About SMO Sarah Cannon Research Inst.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
9
Clinical Trials at SMO Sarah Cannon Research Inst.
During the past decade, SMO Sarah Cannon Research Inst. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
2014-07-22
2024-01-30
Active, not recruiting
669
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
2014-10-03
2023-09-20
Active, not recruiting
453
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
2015-04-20
2019-11-08
Completed
162
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
2015-01-20
2020-08-14
Completed
645
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
2015-07-13
2022-07-26
Completed
530
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
2015-07-01
2017-09-01
Terminated
31
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
2015-09-14
2023-12-31
Active, not recruiting
509
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "SMO Sarah Cannon Research Inst."
#1 collaborator was "SCRI Development Innovations, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at SMO Sarah Cannon Research Inst.
According to Clinical.Site data, the most researched conditions in "SMO Sarah Cannon Research Inst." are
"Brain Metastases" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Epithelial Ovarian Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "SMO Sarah Cannon Research Inst." in a lesser frequency.
Clinical Trials Intervention Types at SMO Sarah Cannon Research Inst.
Most popular intervention types in "SMO Sarah Cannon Research Inst." are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Abemaciclib" (3 trials), "Ramucirumab" (3 trials), "Capecitabine" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SMO Sarah Cannon Research Inst.
The vast majority of trials in "SMO Sarah Cannon Research Inst." are
7 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at SMO Sarah Cannon Research Inst.
Currently, there are NaN active trials in "SMO Sarah Cannon Research Inst.".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in SMO Sarah Cannon Research Inst.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SMO Sarah Cannon Research Inst., 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".